Xtant Medical Holdings, Inc. Share Price
AMEX: XTNT | Micro CapXtant Medical Holdings, Inc. Stock Performance
Open $0.35 | Prev. Close $0.33 | Circuit Range N/A |
Day Range $0.34 - $0.48 | Year Range $0.28 - $0.93 | Volume 2,66,218 |
Average Traded $0.40 |
Xtant Medical Holdings, Inc. Share Price Today
As of 29 August 2026, Xtant Medical Holdings, Inc.'s share price is $0.41. The stock opened at $0.35, compared to its previous close of $0.33. During today's trading session, Xtant Medical Holdings, Inc.'s share price traded between $0.34 and $0.48, with an average price of $0.41. Over the past 52 weeks, the stock has recorded a high of $0.93 and a low of $0.28. In terms of performance, Xtant Medical Holdings, Inc.'s share price has declined by 28.86% over the last six months and is down 34.60% on a year-on-year basis.
Xtant Medical Holdings, Inc. Share Price Chart
Xtant Medical Holdings, Inc. Stock Fundamentals & Key Indicators
Market Cap $56.58M | PE Ratio (TTM) 10.14 | Dividend Yield N/A |
EPS (TTM) $0.04 | Revenue (TTM) $133.93M | Return On Equity (TTM) 9.76% |
Profit Margin 3.71% | Debt to Equity 0.58 | Quarterly Earnings Growth YoY 126.04% |
Xtant Medical Holdings, Inc. Quarterly Profit & Loss
All figures in USD
Xtant Medical Holdings, Inc. Annual Profit & Loss
All figures in USD
About Xtant Medical Holdings, Inc.
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. The company offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, which can be compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically processed and viable bone allograft; and nanOss products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also provides sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, the company offers cervical products comprising Spider cervical plating, Streamline OCT, and CervAlign systems; thoracolumbar products consisting of Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation, and HPS 2.0 hybrid performance systems; and Silex sacroiliac joint fusion systems. Further, it provides interbody products comprising Calix for cervical and thoracolumbar applications, Irix-C Cervical and Irix-A lumbar integrated dusion systems, and Fortilink implants; and interlaminar stabilization products, such as Coflex device for lumbar spinal stenosis; and CoFix implants for back and disc pain. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.
Xtant Medical Holdings, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $0.35 | $0.33 | -22.86% |
Jul 2026 | $0.42 | $0.43 | +0.46% |
Jun 2026 | $0.46 | $0.43 | -6.71% |
May 2026 | $0.55 | $0.46 | -14.44% |
Apr 2026 | $0.51 | $0.54 | -5.26% |
Mar 2026 | $0.57 | $0.57 | +0.00% |
Feb 2026 | $0.61 | $0.57 | -5.00% |
Jan 2026 | $0.76 | $0.60 | -23.08% |
Dec 2025 | $0.59 | $0.78 | +36.60% |
Nov 2025 | $0.86 | $0.57 | -34.67% |
Oct 2025 | $0.64 | $0.87 | +34.88% |
Sep 2025 | $0.63 | $0.65 | +4.52% |